Background: Lyme disease, caused by various species of Borrelia, is transmitted by Ixodes ticks in North America and Europe. Studies have shown the genotype of Borrelia burgdorferi sensu stricto (s.s.) or the species of B. burgdorferi sensu lato (s.l.) affects the ability of the bacteria to cause local or disseminated infection in humans.
Introduction
Borrelia burgdorferi sensu stricto is a bacterial spirochete that is one of the causative agents of Lyme disease [1, 2, 3] . Human risk for the disease may be dependent on a complex interaction between environment and vector [1] with transmission of the resultant bacterial genotypes an essential determinant of disease.
B. burgdorferi is transmitted by Ixodes ticks: I. scapularis and I. pacificus in North America and I. ricinus in Europe [2, 3, 4] . The tick often acquires the spirochetes during its larval stage by feeding on an infected host, usually small rodents [5] . After molting, the nymphs feed on small mammals or birds; adults primarily on deer. It is during these feedings as a nymph or adult that the spirochetes from an infected tick can be transmitted to a new host. Humans, although not part of the natural enzootic cycle, can become infected with B. burgdorferi after being bitten by an infected tick, primarily by nymphs due to their small size. Lyme disease in humans may be localized to the site of the tick bite and is often characterized by the almost pathognomonic bull's-eye-like lesion called erythema migrans (EM). In other cases, the infection may disseminate and produce systemic pathology affecting other skin sites, the nervous system, the joints, or the heart [6, 7, 8, 9] .
In the past, researchers often classified B. burgdorferi s.s. by the type of outer surface protein C (ospC) expressed [10, 11] . There is a demonstrated correlation between ospC type and the rodent host [12] , suggesting that some host species only carry B. burgdorferi s.s. expressing a certain ospC type. Studies have shown that patients who present with localized disease (i.e., a single bull's-eye lesion) have a small subset of ospC types relative to the ospC types found in ticks from the entire region. A smaller subset of ospC types has been found in patients with systemic disease, suggesting that the ospC type may be one marker for disease dissemination in humans [10] .
Multilocus sequence typing (MLST) and multilocus variablenumber tandem repeat (VNTR) analysis has been used to distinguish B. burgdorferi sensu stricto and sensu lato isolates and examine their evolutionary lineage [13, 14, 15, 16] . MLST has been shown to have a higher resolving power than other methods [15] . However, traditional MLST requires sequencing of each locus to define the genotype and cannot resolve mixtures of genotypes. Multilocus PCR followed by electrospray ionization mass spectrometry (PCR/ESI-MS) has been used to genotype a number of medically relevant organisms [17, 18, 19, 20, 21, 22] and to detect tick-borne pathogens in clinical specimens [23] 
Materials and Methods

Multilocus PCR/ESI-MS genotyping assay
The PCR/ESI-MS genotyping assay employs eight PCR primer pairs that target seven Borrelia genes ( Table 1) . The primers are designed to amplify and distinguish all known Borrelia species by targeting conserved regions of DNA that amplify variable regions. All primers used in this study had a thymine nucleotide at the 59-end to minimize the addition of non-templated adenosines during amplification with Taq polymerase [24] . An internal positive control (calibrant) made from synthetic DNA (BlueHeron Biotechnology, Bothell, WA) was included in each PCR reaction at 50 copies per PCR reaction. The calibrant sequence contains a five-base pair (bp) deletion within the amplicon so that the calibrant amplicons can be resolved from the bacteria-derived amplicons; the calibrant serves as an internal positive PCR control and allows quantification of amplicons in the PCR reaction. Nucleic acid extract from individual ticks was added to each of eight wells of 96-well plates containing everything required for PCR except the template DNA. PCR was performed in a 40-mL reaction containing 1 mL nucleic acid, 1 unit of Immolase Taq The PCR cycle ended with a final extension of 2 min at 72uC followed by a 4uC hold. The cycled PCR plates were then processed on the Ibis Bioscience (Carlsbad, CA) T5000 ESI-MS system.
ESI-MS and base composition analysis
The base composition of the PCR amplicons was determined by ESI-MS using the Ibis Biosciences T5000 system as previously described [21, 25, 26] .
Borrelia isolates and nucleic acid extraction
Borrelia isolates were characterized from nucleic acid extracted from cultured isolates, field-collected ticks, and a clinical specimen. Adult and nymphal Ixodes ticks were collected in New York, Connecticut, California, Indiana, and southern Germany ( Table 2 ). The species of the tick was determined by a trained entomologist. Ticks from the United States were collected through use of a drag cloth. Total nucleic acids were extracted from ticks from North American and from skin biopsy as previous described [27] . Briefly, the specimens were homogenized by bead-beating with zirconia/ yttria beads (Glen Mills, Clifton, NJ) and the nucleic acids were extracted using a modified Qiagen MinElute Virus spin kit protocol. Nucleic acids were eluted in AVE buffer (Qiagen) and stored at 280uC. Cultured isolates were provided by Barbara J. Johnson at the CDC in Ft. Collins, CO. DNA was extracted from these isolates by diluting the sample in water and heating to 95uC for 10 min. DNA from isolates previously characterized by their ospC type was provided by the laboratory of Benjamin Luft at Stony Brook University, NY [28] .
Ixodes ricinus ticks were collected either in the area of Constance by flagging (Lake Constance, Southern Germany) or obtained from patients living in the southwestern parts of Germany. All ticks were visually identified as I. ricinus by an entomologist. DNA from large Ixodes ricinus ticks was obtained by slicing the ticks open using a sterile single-use scalpel blade and transferring the material to a 1.5 mL reaction tube, containing 200 mL QIAGEN's ATL-buffer (QIAamp DNA Mini Kit; QIAGEN, Hilden, Germany). Nymphs and larvae were transferred into 1.5 mL reaction tubes, containing 200 mL ATL-buffer and squeezed with a single use, sterile PP pistil (Carl Roth, Karlsruhe, Germany). The crude lysates were digested for a minimum of 3 h (nymphs and larvae) and a maximum overnight (adults) after addition of 20 mL Proteinase K. After brief centrifugation, supernatants were transferred to sterile 2.0 mL screw capped tubes (Sarstedt, Nümbrecht, Germany). DNA was extracted in a QIAcube instrument, applying the protocol ''QIAamp DNA MiniBlood or body fluid-Manual Lysis'', available from the QIAGEN homepage. The elution volume was set to 200 mL.
Data analysis and interpretation
The basecount signature was used to determine the genotype of a Borrelia-containing specimen. If two isolates differed by a single base count they were considered to be unique genotypes. Primer pairs BCT3514 and BCT3515 were principally used to determine the species of Borrelia and the remaining primer pairs were used to genotype the organisms. When more than one allele was detected for any of the gene targets, the sample was considered to contain a mixture of Borrelia burgdorferi genotypes. If a mixture differed at more than one of the eight loci, we required a 1.5-fold difference in the amplitudes to assign the alleles to the major and minor contributors. When the mixtures were present at equal levels the genotypes could not be resolved.
Results
Multilocus PCR/ESI-MS genotyping of Borrelia
The multilocus PCR/ESI-MS genotyping assay was evaluated by testing 351 Borrelia burgdorferi s.l. positive specimens: 61 cultured isolates from North America and Europe, 256 B. burgdorferi s.s. infected field-collected ticks from North America and 34 ticks infected with Borrelia from Europe ( Table 2 ). These analyses resulted in the identification of 53 distinct B. burgdorferi s.s. genotypes as shown in Table 3 . Primer pairs BCT3514 and BCT3515 produced a consistent signature for B. burgdorferi s.s., but distinguish other members of the B. burgdorferi s.l. complex: B. afzelii, B. garinii, B. valaisiana, B. andersonii, B. bissettii, and B. lusitaniae (Table S1 ). The allelic diversity of the loci ranged from a high of 21 alleles for primer pair BCT3518 (targeting the OspC gene) to a low of four alleles for primer pair BCT3514, which was used to identify the Borrelia species. The multilocus PCR/ESI-MS genotyping assay identified nine genotypes of B. afzelii and four genotypes of B. garinii. All eight primer pairs detected a unique base count signature for B. valaisiana, B. andersonii, B. bissettii, and B. lusitaniae, but because there was only one isolate of each we could not demonstrate the assay's ability to genotype these species (Table 4) . One sample of B. spielmanii was also detected on six of the eight primer pairs. Additionally, the assay was able to genotype B. burgdorferi directly from a skin biopsy from a patient presenting with erythema migrans. Results of this analysis showed the patient was infected with our genotype 33 (specimen NJ1, Table 3 ). 
Comparison of multilocus PCR/ESI-MS genotyping with ospC typing
A previously characterized collection of 52 isolates representing 18 ospC types were analyzed using the multilocus PCR/ESI-MS genotyping assay. For the 18 different ospC types examined, we observed 21 different multilocus PCR/ESI-MS genotypes. The results of this analysis are summarized in Table 5 .
Characterization of Borrelia burgdorferi s.s. in Ixodes ticks
Nucleic acids were extracted from the ticks and screened for B. burgdorferi using primer pair BCT3515. A total of 501 Ixodes scapularis ticks (403 adults and 98 nymphs) were collected and analyzed from one site in Indiana (adults), five sites in New York (adults and nymphs), and one site in Connecticut (adults) during the 2008 and 2009 tick seasons. During the same years, 948 Ixodes pacificus ticks (904 adults and 44 nymphs) were collected and analyzed from 18 sites in California (Table 2 ). New York State had a B. burgdorferi infection rate of 59.6% in adult ticks and 45.8% in nymphs. It should be noted that the nymphal ticks obtained from Dutchess county NY were dead and dessicated at the time of testing, potentially affecting B. burgdorferi detections, and therefore were excluded from the infection rate determination. Connecticut had a higher infection rate with 67 of the 99 adult ticks positive for B. burgdorferi (67.7%). In Indiana 19 of 81 of adults ticks sampled (23.5%) were infected with B. burgdorferi. California had the lowest infection rate with 12 of 904 adult I. pacificus ticks and 3 of 44 nymphs (1.4% and 6.8% respectively) positive for B. burgdorferi, ( Table 2) .
We were able to determine the genotypes of 139 of the 219 B. burgdorferi s.s. positive adult I. scapularis ticks. The remaining 80 samples contained either un-typable B. burgdorferi mixtures (n = 30), or there was insufficient DNA from the specimen to enable a full genotype analysis (n = 50). The predominant genotypes by region were: New York (8, 11, 12 and 23), Connecticut (11, 1, 12, and 7) and Indiana (39, 32 and 11) and represented 40%, 57% and 64% of the infected ticks, respectively (Figure 1 ). Nine of 15 B. burgdorferi s.s. positive adult I. pacificus ticks from Northern California were genotyped and found to predominately contain genotypes 2 and 4 ( Figure 1) .
B. burgdorferi s.s. genotypic diversity by geographic region
We compared the genetic diversity of B. burgdorferi in our fieldcollected specimens and culture isolates at the local level (New York vs. Connecticut), the regional level (Northeast vs. Indiana vs. California) and the continental level (North America vs. Europe), as shown in Figure 2A , B, and C respectively. Single specimens containing a resolvable mixture of genotypes were treated as separate counts for determining genotype frequency for the area.
In each region studied, a few genotypes were responsible for the majority of the B. burgdorferi infections (Figure 1 ). Proximal Connecticut and New York shared the highest percentage of common genotypes: 79% of CT genotypes were also observed in NY and 48% of NY genotypes were also observed in CT (Figure 2A) . In examining North America, we grouped CT and NY (designated NE for Northeastern US) together due to their close proximity and the extent of shared genotypes. We found two genotypes (32 and 34) common to California, Indiana, and the Northeast ( Figure 2B ). Indiana shared 77% of its genotypes with the Northeast while 57% of California's genotypes were also found in the Northeast. In the comparison of North American to European isolates ( Figure 2C ), only three genotypes were found on both continents. Of the B. burgdorferi s.s. genotypes observed in North America and Europe, only 6.6% of US genotypes (3 out of 45) were found in Europe and 27% of the European genotypes (3 of 11) were observed in the US.
Characterization of genotypic Borrelia mixtures in Ixodes ticks
Of the 169 B. burgdorferi-positive adult I. scapularis ticks we characterized, 62% (n = 104) had a single genotype, 34% (n = 57) contained two genotypes and 5% (n = 8) had three or more genotypes (Figure 3) . In those specimens with mixtures of more than one genotype, we were able to determine the individual B. burgdorferi genotypes in 52% of the specimens (34 of 65) based upon difference in the allele amplitude as described above in the methods section and shown in Figure 3A . Additionally, one of eleven B. burgdorferi infected nymphs from Suffolk County, NY was found to be infected with a mixture of two B. burgdorferi genotypes (genotypes 22 and 41). The proportion of B. burgdorferi s.s. genotypes per infected adult Ixodes scapularis ticks from Indiana, Connecticut, and New York is shown in Figure 3B .
Borrelia burgdorferi s.l. genotyping of I. ricinus ticks from Southern Germany 178 I. ricinus ticks were tested for the presence of Borrelia on the genotyping assay and 36 were found to have Borrelia (20.2%). The majority of the positive samples were B. afzelii (n = 23) followed by B. garinii (n = 6) and B. burgdorferi s.s. (n = 3), B. valaisiana (n = 2), B. lusitaniae (n = 1), B. spielmanii (n = 1). In total 20 of the 36 samples positive for Borrelia were genotyped. The remaining samples contained un-genotypable mixtures or had limited levels of DNA. Mixtures of Borrelia genotypes were also observed in the I. ricnius ticks with 8 (22.2%) of the 36 Borrelia positive specimens having two or more genotypes present. Five of the eight had a mixture of two genotypes while the remaining samples had 3 or more genotypes present. Three of the mixtures were resolved to their individual genotypes. Five of the mixtures were of B. afzelii genotypes, one a mixture of B. garinii, one was a mixture of B. lusitaniae genotypes, and one a mixture of B. valaisiana.
Discussion
Lyme disease, caused by B. burgdorferi, has symptoms which are usually nonspecific, consisting of fever, fatigue, chills, headache, and muscle aches. In some cases, signs of the disease remain localized to an EM. In other cases there are signs of dissemination into systemic disease such as multiple erythema migrans lesions, central and peripheral neurologic abnormalities, cardiac impair- ment, and swelling of large joints. Different strains of B. burgdorferi have been associated with varying pathogenicities in the human host, with some strains more often observed in disseminated infections [10, 29] . Previous studies have shown that certain strains of B. burgdorferi are more likely to cause an erythema migrans and/ or disseminate through the body [10, 30] . The ability to quickly identify the Borrelia species and associate particular genotypes with certain symptoms can have important patient-management implications. For example, the clinical observation of a single erythema migrans lesion where at least one of the recovered spirochetes is associated with an invasive phenotype might alert the treating physician to consider the use of an antibiotic, such as an intravenously administered one, that will reliably penetrate the central nervous system [31, 32] or, at the very least, the physician would monitor the patient for development of neurologic symptoms even with administration of oral antibiotics.
Previous studies have also shown culturing spirochetes from ticks or clinical specimens can alter the genotypes observed as compared to those obtained from direct PCR [33, 34] . Using our rapid multilocus PCR/ESI-MS genotyping assay, we have demonstrated that we can genotype B. burgdorferi directly from adult or nymphal ticks without the need for culture. Additionally, we have shown that our PCR/ESI-MS method can be used to detect and genotype B. burgdorferi directly from a clinical specimen. The PCR/ESI-MS genotyping assay has the added benefit of being able to identify the species and genotype a variety of Borrelia that can cause Lyme disease.
Studies have shown that the multilocus sequence typing (MLST) approach provides a finer separation of strains than does typing based on the ospC gene alone [15] . Using our multilocus PCR/ESI-MS genotyping assay, several ospC groups were subdivided into multiple genotypes. In North America we observed 44 different genotypes of B. burgdorferi, 35 of which were found at sites within 100 miles of each other, which could indicate a much more diverse population of B. burgdorferi than previously described.
In this study, we found that Borrelia infection rates in adult I. scapularis ticks from the northeastern US were similar to those observed previously [4, 35, 36] ; B. burgdorferi infection rates were relatively lower in Indiana and California. An earlier study utilizing an MLST approach reported that no genotypes were shared between the Northeastern United States and the Midwest (with Ohio being the dividing state) [37] . In contrast to this observation, we found two genotypes in all three regions of the United States. Although our sample sizes from the Midwest and California were lower, the presence of these genotypes in each region may indicate that there was a widespread expansion of a few clonal isolates across North America followed by subsequent local diversification.
Past studies employing either single-strand conformation polymorphism (SSCP) or reverse line blotting (RLB) have shown that ticks can be infected with more than one strain of B. burgdorferi [4, 38] . Due to the limits of DNA sequencing, MLST approaches cannot resolve mixtures without culture. Due to the capability of mass spectrometry to resolve mixtures, our PCR/ESI-MS genotyping assay could detect and frequently resolve specimens containing a mixture of more than one genotype. Of the 169 B.
burgdorferi positive I. scapularis ticks characterized from the US, 39% contained two or more genotypes. Of the 36 Borrelia positive I. ricinus ticks from Europe, we found 22.2% containing more than one pathogenic species/member of Borrelia burgdorferi sensu lato complex. These findings indicate genotype mixtures in ticks are common in both Europe and North America. Our finding of a nymph (which has fed only once) with multiple genotypes and 5% of the adult ticks (which have fed twice), with three or more genotypes indicates that ticks can become infected with more than one genotype of B. burgdorferi from a single feeding. Further studies are needed to determine if certain combinations of genotypes are more likely to co-infect a tick or cause disease in humans.
In this study we developed a very high resolution Borrelia genoptying assay that can genotype directly from a variety of sample types and discriminate Borrelia mixtures. We found a diversity of genotypes across geographic regions. This capability to rapidly identify and genotype Borrelia may facilitate better management of patients with Lyme disease and provide a better understanding of the association of Borrelia genotypes and disease. Our findings also underscore the importance of collaborations between scientists with environmental and microbial ecology expertise [1, 12] along with those in health related research. While our findings, which were not designed to be comprehensive, provides the impetus and shows the feasibility to explore other areas where Lyme is being to reported such as the southern US and northern Mexico. Such studies can contribute to a broader epidemiologic assessment of the breadth of potential Lyme disease in North America. Future studies focusing on Borrelia genotypes in nymphs will further define their genotypic co-infection rates and determine if certain genotypes tend to preferentially co-infect. The findings here indicate that the diversity of genotypes in ticks known to cause Lyme disease is greater then previously described and that Borrelia may frequently exist as genotypic mixtures in the environment. 
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